Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 4/2010

01-04-2010 | Hepatobiliary Tumors

Predictors of Survival in Periampullary Cancers Following Pancreaticoduodenectomy

Authors: Ioannis Hatzaras, MD, MPH, Nathaniel George, BS, Peter Muscarella, MD, W. Scott Melvin, MD, E. Christopher Ellison, MD, Mark Bloomston, MD

Published in: Annals of Surgical Oncology | Issue 4/2010

Login to get access

Abstract

Background

Cancers of the ampulla of Vater, distal common bile duct, and pancreas are known to have dismal prognosis. It is often reported that ampullary cancers are less aggressive relative to the other periampullary carcinomas. We sought to evaluate predictors of survival for periampullary cancers following pancreaticoduodenectomy to identify biologic behavior.

Methods

We reviewed the records of all patients who underwent pancreaticoduodenectomy for periampullary carcinoma between 1992 and 2007 at the Ohio State University Medical Center. Demographics, treatment, and outcome/survival data were analyzed. Kaplan–Meier survival curves were created and compared by log-rank analysis. Multivariate analysis was undertaken using Cox proportional-hazards method.

Results

346 consecutive periampullary malignancies (249 pancreatic cancers, 79 ampullary carcinomas, 18 extrahepatic cholangiocarcinomas) treated by pancreaticoduodenectomy were identified. Pancreatic cancer histology correlated with the shortest median survival (17.1 months), followed by cholangiocarcinoma (17.9 months) and ampullary carcinoma (44.3 months) (P < 0.001). Potential predictors of decreased survival on univariate analysis included site of origin, preoperative jaundice, microscopic positive margin, nodal metastasis, lymphovascular invasion, neural invasion, and poor differentiation. Only nodal metastasis (median 16.2 versus 29.9 months, P < 0.001) and neural invasion (median 17.7 versus 47.9 months, P < 0.00001) significantly predicted outcome on multivariate analysis.

Conclusions

Although ampullary cancers have the best prognosis overall, when controlled for tumor stage, only presence of neural invasion and nodal metastasis predict poor survival following pancreaticoduodenectomy. Biological behavior remains the most important prognostic indicator in periampullary cancers amenable to resection, regardless of site of origin.
Literature
1.
Sarmiento JM, Nagomey DM, Sarr MG, Farnell MB. Periampullary cancers: are there differences? Surg Clin North Am. 2001;81(3):543–55.CrossRefPubMed
2.
Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 1991;161(1):120–4; discussion 124–5.
3.
Yeo CJ, Sohn TA, Cameron JL, et al. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg. 1998;227(6):821–31.CrossRefPubMed
4.
Androulakis J, Colborn GL, Skandalakis PN, et al. Embryologic and anatomic basis of duodenal surgery. Surg Clin North Am. 2000;80(1):171–99.CrossRefPubMed
5.
Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8–13.CrossRefPubMed
6.
Riall TS, Cameron JL, Lillemoe KD, et al. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery. 2006;140(5):764–72.CrossRefPubMed
7.
Kang CM, Kim DH, Choi GH, et al. Detrimental effect of postoperative complications on oncologic efficacy of R0 pancreatectomy in ductal adenocarcinoma of the pancreas. J Gastrointest Surg. 2009;13:907–14CrossRefPubMed
8.
Kayahara M, Nagakawa T, Ueno K, et al. Lymphatic flow in carcinoma of the distal bile duct based on a clinicopathologic study. Cancer. 1993;72(7):2112–7.CrossRefPubMed
9.
Liu B, Lu KY. Neural invasion in pancreatic carcinoma. Hepatobiliary Pancreat Dis Int. 2002;1(3):469–76.PubMed
10.
Nakao A, Harada A, Nonami T, et al. Lymph node metastases in carcinoma of the head of the pancreas region. Br J Surg. 1995;82(3):399–402.CrossRefPubMed
11.
Monson JR, Donohue JH, McEntee GP, et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg. 1991;126(3):353–7.PubMed
12.
Kurosaki I, Tsukada K, Hatakeyama K, Muto T. The mode of lymphatic spread in carcinoma of the bile duct. Am J Surg. 1996;172(3):239–43.CrossRefPubMed
13.
Nakai T, Koh K, Kawabe T, et al. Importance of microperineural invasion as a prognostic factor in ampullary carcinoma. Br J Surg. 1997;84(10):1399–401.CrossRefPubMed
14.
Tomazic A, Pegan V, Ferlan-Marolt K, et al. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma. Hepatogastroenterology. 2004;51(60):1832–7.PubMed
15.
Mori M, Adachi Y, Kamakura T, et al. Neural invasion in gastric carcinoma. J Clin Pathol. 1995;48(2):137–42.CrossRefPubMed
16.
Ancona E, Rampado S, Cassaro M, et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol. 2008;15(11):3278–88.CrossRefPubMed
17.
Horn A, Dahl O, Morild I. The role of venous and neural invasion on survival in rectal adenocarcinoma. Dis Colon Rectum. 1990;33(7):598–601.CrossRefPubMed
18.
Chan C, Herrera MF, de la Garza L, et al. Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg. 1995;222(5):632–7.CrossRefPubMed
19.
Howard TJ, Krug JE, Yu J, et al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg. 2006;10(10):1338–45; discussion 1345–6.
20.
Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007;246(1):52–60.CrossRefPubMed
21.
Butturini G, Stocken DD, Wente MN, et al. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg. 2008;143(1):75–83.CrossRefPubMed
22.
Dillhoff M, Yates R, Wall K, et al. Intraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancer. J Gastrointest Surg. 2009;13(5):825–30.CrossRefPubMed
23.
Verbeke CS, Menon KV. Redefining resectionmargin status in pancreatic cancer. HPB (Oxford). 2009;11(4):282–9.
24.
Esposito I, Kleeff J, Bergmann F, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008;15(6):1651–60.CrossRefPubMed
25.
Howard TJ, Krug JE, Yu J, et al. A margin-ngative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg. 2006;10(10):1338–45.CrossRefPubMed
Metadata
Title
Predictors of Survival in Periampullary Cancers Following Pancreaticoduodenectomy
Authors
Ioannis Hatzaras, MD, MPH
Nathaniel George, BS
Peter Muscarella, MD
W. Scott Melvin, MD
E. Christopher Ellison, MD
Mark Bloomston, MD
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 4/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0883-9

Other articles of this Issue 4/2010

Annals of Surgical Oncology 4/2010 Go to the issue

Endocrine Tumors

Occult Contralateral Carcinoma in Patients with Unilateral Papillary Thyroid Microcarcinoma

Gynecologic Oncology

Endometrial Carcinoma with Extra-abdominal Metastasis: Improved Prognosis Following Cytoreductive Surgery

Head and Neck Oncology

Long-Term Single-Center Results of Management of Ethmoid Adenocarcinoma: 95 Patients over 28 Years

Translational Research and Biomarkers

Associations of MDM2 SNP309, Transcriptional Activity, mRNA Expression, and Survival in Stage I Non-Small-Cell Lung Cancer Patients with Wild-Type p53 Tumors

Gastrointestinal Oncology

Enhancement the Prediction of Postoperative Survival in Gastric Cancer by Combining the Negative Lymph Node Count with Ratio Between Positive and Examined Lymph Nodes

Hepatobiliary Tumors

Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases